Overview
The purpose of this post-marketing surveillance is to evaluate the effectiveness and safety of GORE® CARDIOFORM Septal Occluder under the post-marketing setting in Japan.
Eligibility
Inclusion Criteria:
- Diagnosed with cryptogenic stroke (including transient ischemic attack with positive head imaging findings)
- Diagnosed with a PFO
- Note: Additional Inclusion Criteria may apply
Exclusion Criteria:
- N/A
